"Designing Growth Strategies is in our DNA"
The global hospice care market size was valued at USD 44.38 billion in 2025. The market is projected to grow from USD 47.25 billion in 2026 to USD 82.71 billion by 2034, exhibiting a CAGR of 7.3% during the forecast period.
Hospice care refers to a coordinated, interdisciplinary model of end-of-life care that focuses on comfort, symptom management, and quality of life for patients with a terminal prognosis, rather than curative treatment. Services are delivered across a range of settings, including the patient's home, dedicated hospice facilities, and hospitals, and combine nursing care, physician oversight, counseling, spiritual support, and caregiver assistance. The market is growing as aging populations, rising rates of cancer, dementia, and chronic cardiovascular and respiratory disease, and a strengthening policy and reimbursement environment push more patients into structured end-of-life care pathways. The market growth is also supported by increasing patient and family preference for home-based care, expanding hospice bed and program capacity, and continued investment from both non-profit and for-profit providers.
Furthermore, Gentiva, VITAS Healthcare Corporation, Optum, Inc., Chapters Health System, Inc., and AccentCare, Inc. held the largest market share, driven by increasing investments and planned initiatives, such as facility expansions, partnerships, and acquisitions.
Integration of Telehealth and Remote Patient Monitoring is an Emerging Trend Observed in the Market
A clear market trend is the shift from stand-alone home visits toward technology-enabled hospice care models. Providers increasingly want tools that support remote symptom tracking, virtual physician check-ins, and caregiver communication alongside in-person nursing visits, rather than relying on visit-based care alone. This is particularly visible in North America and parts of Europe, where hospice operators are layering telehealth, remote patient monitoring, and electronic health record integration onto their existing interdisciplinary teams to extend clinical oversight between visits and respond faster to changes in patient condition.
Download Free sample to learn more about this report.
Growing Burden of Chronic and Terminal Illness Among an Aging Population to Drive Market Growth
One of the strongest global hospice care market growth drivers is the steady increase in the global population aged 65 and above, combined with a persistent and rising burden of cancer, dementia, and chronic cardiovascular and respiratory disease. Hospice care has become deeply embedded in end-of-life practice as it allows interdisciplinary teams to manage pain, symptoms, and psychosocial needs while avoiding the burden of repeated hospitalizations for patients with a limited prognosis. As health systems worldwide face growing pressure from an aging patient base, providers and payers are investing more heavily in structured hospice pathways that improve quality of life and reduce avoidable acute care utilization.
Market Drivers - Impact & CAGR Contribution (2026–2034)
| Rank | Market Driver | Overall Impact | CAGR Contribution, 2026–2034 | Impact: 2026-2028 | Impact: 2029-2031 | Impact: 2032-2034 |
|---|---|---|---|---|---|---|
| 1 | Ageing population and rising number of patients with life-limiting chronic diseases | High | 2.5% | High | High | High |
| 2 | Increasing hospice utilization, awareness, and preference for home/community-based end-of-life care | High | 2.1% | High | High | High |
| 3 | Expansion of government reimbursement, insurance coverage, and hospice funding | High | 1.8% | High | High | Medium |
| 4 | Expansion of hospice provider networks, service capacity, and geographic accessibility | Medium | 1.5% | Medium | High | High |
| 5 | Growing adoption of telehospice, digital care coordination, and remote patient-management solutions | Medium | 1.1% | Medium | Medium | High |
| 6 | Others | Low | 0.9% | Low | Low | Low |
| Total Positive Growth Contribution | 9.90% | |||||
Source: Fortune Business Insights
Workforce Shortages and Staffing Constraints to Restrict Market Growth
A major restraint for this market is the ongoing shortage of qualified hospice nurses, physicians, social workers, and chaplains. Growing patient volumes are placing sustained pressure on existing workforce capacity, and recruitment and retention challenges are increasing operational costs for providers, particularly in rural and underserved regions. In several markets, hospice agencies have reported declining admissions specifically due to staffing constraints rather than a lack of patient demand, which can slow purchasing decisions around new programs and delay geographic expansion.
Market Restraints - Impact & Negative CAGR Contribution (2026–2034)
| Rank | Market Restraints | Overall Impact | CAGR Contribution, 2026–2034 | Impact: 2026-2028 | Impact: 2029-2031 | Impact: 2032-2034 |
|---|---|---|---|---|---|---|
| 1 | Shortage of skilled hospice workforce and rising labor costs | High | -1.2% | High | High | Medium |
| 2 | Stringent reimbursement, eligibility, quality-reporting, audit, and compliance requirements | High | -0.8% | High | High | Medium |
| 3 | Uneven hospice accessibility, low awareness, and late referrals, particularly in underserved markets | Medium | -0.63% | High | Medium | Medium |
| 4 | Others | Low | -0.2% | Low | Low | Low |
| Total Negative Restraint Contribution | -2.83% | |||||
Source: Fortune Business Insights
Rising Private-Equity Investment and Consolidation Activity to Offer Significant Market Opportunities
The market offers significant opportunities as private equity firms and larger healthcare organizations continue to invest in hospice care, drawn by favorable demographic trends and recurring, government-supported demand. Mergers and acquisitions are giving operators a way to expand geographic reach, improve operational efficiency, and strengthen their position across home-based, facility-based, and general inpatient hospice care.
Complex and Evolving Reimbursement Landscape to Challenge Market Growth
Despite its clinical value, hospice care still faces real-world challenges that can limit adoption and scale-up. Programs depend on close coordination between clinicians, families, and payers, and outcomes can vary between high-volume, well-established providers and smaller or newer agencies. Providers need trained interdisciplinary teams, community relationships, and referral pipelines from hospitals and physicians, all of which create a meaningful entry barrier for smaller operators, particularly in rural and underserved regions.
Routine or Standard Hospice Care Segment Dominated the Market Owing to Cost-Effectiveness and Broad Patient Eligibility
Based on the care model, the market is divided into routine or standard hospice care, continuous or crisis hospice care, general inpatient hospice care, inpatient respite care, and others.
The routine or standard hospice care segment accounted for the largest share of the global market in 2025. Routine hospice care is the most widely utilized care model as it enables patients with terminal illnesses to receive comprehensive palliative services in their preferred care setting while maintaining comfort and quality of life. The model offers coordinated physician oversight, nursing care, pain and symptom management, counseling, and caregiver support at a relatively lower cost than continuous home care or inpatient hospice services. Additionally, favorable reimbursement policies across developed countries and the growing preference for home-based end-of-life care continue to support the segment's dominant market position.
The continuous or crisis hospice care segment is anticipated to grow with a CAGR of 8.4% over the forecast period.
To know how our report can help streamline your business, Speak to Analyst
Home-Based Hospice Care Segment Held the Leading Share Due to Growing Preference for Receiving End-of-Life Care at Home
Based on care settings, the market is segmented into home-based hospice care, dedicated hospice facilities, hospitals, and others.
In 2025, the home-based hospice care segment dominated the global market. The increasing preference among patients and families to receive end-of-life care in familiar surroundings, coupled with improved quality of life and emotional well-being, has significantly driven demand for home hospice services. Home-based care also reduces unnecessary hospital admissions and healthcare expenditures while enabling personalized care through multidisciplinary teams. Furthermore, expanding reimbursement coverage, advancements in remote patient monitoring, and increasing caregiver support programs are accelerating the adoption of home-based hospice services worldwide.
The dedicated hospice facilities segment is anticipated to grow with a CAGR of 8.1% over the forecast period.
Cancer Segment Accounted for the Dominating Share Owing to High Palliative Care Demand
Based on indication, the market is segmented into cancer, dementia and Alzheimer's disease, cardiovascular diseases, chronic respiratory diseases, neurological diseases, and others.
The cancer segment held the leading share of the global market in 2025. Cancer remains one of the leading causes of mortality worldwide, creating a substantial demand for hospice services focused on pain management, symptom control, and psychosocial support during advanced stages of the disease. Patients with terminal cancer frequently require multidisciplinary palliative care to improve comfort and quality of life. Additionally, growing cancer incidence, increasing awareness regarding early integration of palliative care, and supportive reimbursement frameworks continue to strengthen the segment's market leadership.
The dementia and Alzheimer's disease segment is anticipated to grow with a CAGR of 8.5% over the forecast period.
Adult Segment Dominated the Market Due to High Burden of Chronic and Terminal Illnesses
Based on age group, the market is segmented into adult and pediatric.
In 2025, the adult segment held the leading hospice care market share. Adults, particularly the elderly population, represent the majority of hospice care recipients owing to the high prevalence of chronic, life-limiting conditions such as cancer, cardiovascular diseases, chronic respiratory disorders, and neurodegenerative diseases. Increasing global life expectancy, the rising aging population, and greater acceptance of hospice and palliative care services have further contributed to the segment’s growth. Moreover, established clinical guidelines and reimbursement policies for adult hospice care continue to support its widespread adoption across healthcare systems.
The pediatric segment is anticipated to grow at a CAGR of 7.2% over the forecast period.
By region, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.
North America Hospice Care Market Size, 2025 (USD Billion)
To get more information on the regional analysis of this market, Download Free sample
North America held the dominant share in 2024, valued at USD 26.39 billion, and also maintained the leading share in 2025, with USD 27.85 billion. The region’s market is expected to increase due to an aged population, established hospice infrastructure, and broad Medicare and private insurance coverage for end-of-life care.
Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 27.49 billion in 2026, accounting for roughly 58.2% of global sales.
Europe is projected to record a growth rate of 7.1% in the coming years and reach a valuation of USD 9.89 billion by 2026. The region is estimated to witness considerable market growth due to a well-established palliative care ecosystem, rising life expectancy, and continued integration of hospice into statutory health insurance across major markets.
The U.K. market size in 2026 is estimated at around USD 2.36 billion, representing roughly 5.0% of global revenues.
Germany’s market value is projected to reach approximately USD 1.98 billion by 2026, equivalent to around 4.2% of global sales.
Asia Pacific is estimated to reach USD 5.91 billion in 2026, securing a significant position in the market. Substantially increasing chronic diseases and rising government support are boosting the region’s market growth.
The Japan market size in 2026 is estimated at around USD 1.62 billion, accounting for roughly 3.4% of global revenues.
China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 1.90 billion, representing roughly 4.0% of global sales.
The Indian market size in 2026 is estimated at around USD 0.85 billion, accounting for roughly 1.8% of global revenues.
Latin America and the Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 1.21 billion by 2026, driven by expanding home-based palliative services and improving healthcare access. Meanwhile, the Middle East & Africa region’s growth is supported by healthcare infrastructure development and rising palliative-care awareness. In the Middle East & Africa region, the GCC market is set to reach a value of USD 0.34 billion by 2026.
The South Africa market size is projected to reach around USD 0.22 billion by 2026, representing roughly 0.5% of global revenues.
Continued Facility Expansion and Consolidation to Drive Stronger Market Positioning of Leading Players
The global hospice care market has a semi-consolidated competitive structure, comprising prominent players such as Gentiva, VITAS Healthcare Corporation, Optum, Inc., Chapters Health System, Inc., and AccentCare, Inc. These companies hold significant market positions due to their comprehensive portfolio, established global distribution networks, long-standing partnerships, research institutions, and continued investment in technologically advanced care.
Other notable players in the global market include Compassus, BrightSpring Health Services Corporation, Bristol Hospice, LLC, The Pennant Group, Inc., and Addus HomeCare Corporation. These companies are expected to prioritize collaborations to increase their global market share during the forecast period.
The global hospice care market analysis includes a comprehensive study of the market size & forecast by all the market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, as well as key industry developments and investments by key regions. The global market research report also provides a deep competitive landscape with information on the market share and profiles of key operating players.
Request for Customization to gain extensive market insights.
| ATTRIBUTE | DETAILS |
| Study Period | 2021-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2021-2024 |
| Growth Rate | CAGR of 7.3% from 2026-2034 |
| Unit | Value (USD Billion) |
| Segmentation | By Care Model, Care Settings, Indication, Age Group, and Region |
| By Care Model |
|
| By Care Settings |
|
| By Indication |
|
| By Age Group |
|
| By Region |
|
Approach 1 - Country-Level Hospice Utilization & Spending Analysis
Approach 2: Eligible Patient Population, Hospice Penetration & Patient-Day Analysis
Approach 3: Credible Secondary Sources & Institutional Data Cross-Check
Approach 1: Revenues and Market Share of Major Players (2021–2025)
Approach 2: Triangulation, Validation and Forecast Modeling
Supply Side Interviews: 60%
According to Fortune Business Insights, the global market value stood at USD 44.38 billion in 2025 and is projected to reach USD 82.71 billion by 2034.
In 2025, the market value stood at USD 27.85 billion.
The market is expected to exhibit a CAGR of 7.3% during the forecast period.
By care model, the routine or standard hospice care segment is expected to lead the market.
The growing burden of chronic and terminal illness among an aging population to drive market growth.
Gentiva, VITAS Healthcare Corporation, Optum, Inc., Chapters Health System, Inc., and AccentCare, Inc. are the major players in the global market.
North America dominated the market in 2025.
Get 30-60 hrs Free Customization
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )